Simultaneous and sensitive LC-MS/MS determination of tetrahydrocannabinol and metabolites in human plasma

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 4, 2013, Pages 1399-1406

  Ferreiros N ^a   Labocha, S ^a   Walter, C ^a   Lotsch J ^a   Geisslinger, G ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Cannabinoids; LC MS MS; Metabolites; THC

Indexed keywords

BIOMOLECULES; DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NANORODS; PHASE SEPARATION; PLASMA (HUMAN);

CANNABINOIDS; LC-MS/MS; LINEAR CALIBRATION; LIQUID CHROMATOGRAPHIC SEPARATIONS; ORAL ADMINISTRATION; RELATIVE STANDARD DEVIATIONS; SOLID-PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

METABOLITES;

CANNABIS;

EID: 84873751215     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6501-x     Document Type: Article

References (36)

1. EMCDDA (2011) The State of the Drugs Problem in Europe, Annual Report 2011. European Monitoring Centre for Drugs and Drug Addiction
2. Hall W, Degenhardt L (2009) Adverse health effects of non-medical cannabis use. Lancet 374:1383-1391
3. Seely KA, Prather PL, James LP, Moran JH (2011) Marijuana-based drugs: innovative therapeutics or designer drugs of abuse? Mol Interv 11:36-51
4. Husseini L, Leussink VI, Warnke C, Hartung HP, Kieseier BC (2011) Cannabinoids for symptomatic therapy of multiple sclerosis. Nervenarzt. doi: 10.1007/s00115-011-3401-9
5. Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I (2007) Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci 80:1415-1419
6. Watanabe K, Matsunaga T, Yamamoto I, Funae Y, Yoshimura H (1995) Involvement of CYP2C in the metabolism of cannabinoids by human hepatic microsomes from an old woman. Biol Pharm Bull 18:1138-1141
7. Richardson TH, Jung F, Griffin KJ, Wester M, Raucy JL, Kemper B, Bornheim LM, Hassett C, Omiecinski CJ, Johnson EF (1995) A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli. Arch Biochem Biophys 323:87-96
8. Schwope DM, Scheidweiler KB, Huestis MA (2011) Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 401:1273-1283
9. Vree TB, Breimer DD, van Ginneken CA, van Rossum JM, de Zeeuw RA, Witte AH (1971) Identification of cannabivarins in hashish by a new method of combined gas chromatography-mass-spectrometry. Clin Chim Acta 34:365-372
10. Mikes F, Hofmann A, Waser PG (1971) Identification of (-)-delta 9-6a,10a-trans-tetrahydrocannabinol and two of its metabolites in rats by use of combination gas chromatography-mass spectrometry and mass fragmentography. Biochem Pharmacol 20:2469-2476
11. Breindahl T, Andreasen K (1999) Determination of 11-nor-delta9- tetrahydrocannabinol-9-carboxylic acid in urine using high-performance liquid chromatography and electrospray ionization mass spectrometry. J Chromatogr B: Biomed Sci Appl 732:155-164
12. Backstrom B, Cole MD, Carrott MJ, Jones DC, Davidson G, Coleman K (1997) A preliminary study of the analysis of cannabis by supercritical fluid chromatography with atmospheric pressure chemical ionisation mass spectroscopic detection. Sci Justice 37:91-97
13. Elian AA, Hackett J (2009) Solid-phase extraction and analysis of THC and carboxy-THC from whole blood using a novel fluorinated solid-phase extraction sorbent and fast liquid chromatography-tandem mass spectrometry. J Anal Toxicol 33:461-468
14. del Mar Ramirez Fernandez M, de Boeck G, Wood M, Lopez-Rivadulla M, Samyn N (2008) Simultaneous analysis of THC and its metabolites in blood using liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 875:465-470
15. Valiveti S, Hammell DC, Earles DC, Stinchcomb AL (2005) LC-MS method for the estimation of delta8-THC and 11-nor-delta8-THC-9-COOH in plasma. J Pharm Biomed Anal 38:112-118
16. de Jager AD, Bailey NL (2011) Online extraction LC-MS/MS method for the simultaneous quantitative confirmation of urine drugs of abuse and metabolites: amphetamines, opiates, cocaine, cannabis, benzodiazepines and methadone. J Chromatogr B Anal Technol Biomed Life Sci 879:2642-2652
17. Grauwiler SB, Scholer A, Drewe J (2007) Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts. J Chromatogr B Anal Technol Biomed Life Sci 850:515-522
18. Gray TR, Barnes AJ, Huestis MA (2010) Effect of hydrolysis on identifying prenatal cannabis exposure. Anal Bioanal Chem 397:2335-2347
19. Konig S, Aebi B, Lanz S, Gasser M, Weinmann W (2011) On-line SPE LC-MS/MS for the quantification of Delta9-tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 400:9-16
20. Jagerdeo E, Montgomery MA, Karas RP, Sibum M (2010) A fast method for screening and/or quantitation of tetrahydrocannabinol and metabolites in urine by automated SPE/LC/MS/MS. Anal Bioanal Chem 398:329-338
21. Weinmann W, Goerner M, Vogt S, Goerke R, Pollak S (2001) Fast confirmation of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (THC-COOH) in urine by LC/MS/MS using negative atmospheric-pressure chemical ionisation (APCI). Forensic Sci Int 121:103-107
22. Weinmann W, Vogt S, Goerke R, Muller C, Bromberger A (2000) Simultaneous determination of THC-COOH and THC-COOH-glucuronide in urine samples by LC/MS/MS. Forensic Sci Int 113:381-387
23. Felli M, Martello S, Chiarotti M (2011) LC-MS-MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: Application to workplace confirmation tests. Forensic Sci Int 204:67-73
24. Chebbah C, Pozo OJ, Deventer K, Van Eenoo P, Delbeke FT (2010) Direct quantification of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine by liquid chromatography/tandem mass spectrometry in relation to doping control analysis. Rapid Commun Mass Spectrom 24:1133-1141
25. Teixeira H, Proenca P, Castanheira A, Santos S, Lopez-Rivadulla M, Corte-Real F, Marques EP, Vieira DN (2004) Cannabis and driving: the use of LC-MS to detect delta9-tetrahydrocannabinol (delta9-THC) in oral fluid samples. Forensic Sci Int 146(Suppl):S61-S63
26. Molnar A, Lewis J, Doble P, Hansen G, Prolov T, Fu S (2011) A rapid and sensitive method for the identification of delta-9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry. Forensic Sci Int. doi: 10.1016/j.forsciint.2011.01.045
27. Walter C, Oertel BG, Felden L, Nöth U, Deichmann R, Lötsch J (2011) The effects of delta-9-tetrahydrocannabinol on nasal chemosensitivity: a pharmacological fMRI study in healthy volunteers. Naunyn Schmiedebergs Arch Pharmacol 383(Suppl 1):75
28. Guidance for Industry: Bioanalytical Method Validation (2001) US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, USA www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm070107.pdf. Accessed 21 Jun 2012
29. Smith G (2010) Bioanalytical method validation: notable points in the 2009 draft EMA Guideline and differences with the 2001 FDA Guidance. Bioanalysis 2:929-935
30. Validation of Analytical Procedures: Text and Methodology Q2(R1) (2005) ICH. International Conference on Harmonisation of Technical Requirements, ICH Harmonised Tripartite Guideline, Geneva, Switzerland. http://private.ich.org/ LOB/media/MEDIA417.pdf. Accessed 21 Jun 2012
31. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75:3019-3030
32. Wall ME, Perez-Reyes M (1981) The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man. J Clin Pharmacol 21:178S-189S
33. Grotenhermen F (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 42:327-360
34. Dubois N, Paccou AP, De Backer BG, Charlier CJ (2012) Validation of the quantitative determination of tetrahydrocannabinol and its two major metabolites in plasma by ultra-high-performance liquid chromatography-tandem mass spectrometry according to the total error approach. J Anal Toxicol 36:25-29
35. Milman G, Schwope DM, Schwilke EW, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA (2011) Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral delta(9)-tetrahydrocannabinol administration. Clin Chem 57:1597-1606
36. Karschner EL, Darwin WD, Goodwin RS, Wright S, Huestis MA (2011) Plasma cannabinoid pharmacokinetics following controlled oral delta9- tetrahydrocannabinol and oromucosal cannabis extract administration. Clin Chem 57:66-75